These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 14794457)
21. Methods of administering oral formulations and child acceptability. van Riet-Nales DA; Ferreira JA; Schobben AF; de Neef BJ; Egberts TC; Rademaker CM Int J Pharm; 2015 Aug; 491(1-2):261-7. PubMed ID: 26143234 [TBL] [Abstract][Full Text] [Related]
22. Antirheumatic effects of hydrocortisone (free alcohol), hydrocortisone acetate, and cortisone (free alcohol) as compared with cortisone acetate; results from oral administration in patients with rheumatoid arthritis. BOLAND EW Br Med J; 1952 Mar; 1(4758):559-64. PubMed ID: 14904983 [No Abstract] [Full Text] [Related]
23. [Oral use of cortisone in chronic rheumatism therapy]. Med Hyg (Geneve); 1951 Feb; 9(188):67. PubMed ID: 14826093 [No Abstract] [Full Text] [Related]
24. Stability of extemporaneous suspensions of carbamazepine. Burckart GJ; Hammond RW; Akers MJ Am J Hosp Pharm; 1981 Dec; 38(12):1929-31. PubMed ID: 7325176 [TBL] [Abstract][Full Text] [Related]
25. [Oral cortisone administration in rheumatic pancarditis]. KOHL H Dtsch Med Wochenschr; 1951 Oct; 76(42):1300-3. PubMed ID: 14896767 [No Abstract] [Full Text] [Related]
27. Stability of ursodiol in an extemporaneously compounded oral liquid. Johnson CE; Nesbitt J Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836 [TBL] [Abstract][Full Text] [Related]
34. Oral cortisone treatment of infantile eczema. HILL LW N Engl J Med; 1953 Jun; 248(25):1051-6. PubMed ID: 13054885 [No Abstract] [Full Text] [Related]
35. Studies of cerebrospinal fluid following oral administration of cortisone acetate or hydrocortisone. ABELSON D; BARON DN; TOAKLEY JG J Endocrinol; 1955 Mar; 12(2):87-92. PubMed ID: 14367645 [No Abstract] [Full Text] [Related]
36. [Oral treatment of skin diseases with cortisone & prednisone]. STUHLERT H Dermatol Wochenschr; 1957 Mar; 135(12):289-92. PubMed ID: 13427450 [No Abstract] [Full Text] [Related]
37. [Pharmaceutical availability of cortisone acetate from microcrystalline suspensions for injections]. Umer S; Nerlo H Acta Pol Pharm; 1987; 44(2):221-4. PubMed ID: 3434315 [No Abstract] [Full Text] [Related]
38. Stability of extemporaneous pediatric oral liquids compounded from tablets and drug substance: case of propranolol and theophylline. Muśko M; Sznitowska M Acta Pol Pharm; 2013; 70(1):137-45. PubMed ID: 23610969 [TBL] [Abstract][Full Text] [Related]
39. Oral use of cortisone in chronic adrenal cortical insufficiency; study of six cases. LEVY MS J Am Med Assoc; 1952 May; 149(5):411-5. PubMed ID: 14927365 [No Abstract] [Full Text] [Related]
40. [Caution of injections of cortisone-crystal suspensions]. Wolff G Ther Ggw; 1972 Feb; 111(2):247-51. PubMed ID: 5044438 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]